ArticleTherapeutic advances in medical oncology2023

Eribulin combined with antiangiogenic agents in women with HER2-negative metastatic breast cancer: a retrospective multicenter study.

Mingxia Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.